EMEA (Europe, Middle East and Africa) Bio-protein Drug Market Report 2017

EMEA (Europe, Middle East and Africa) Bio-protein Drug Market Report 2017

1 Bio-protein Drug Overview

1.1 Product Overview and Scope of Bio-protein Drug

1.2 Classification of Bio-protein Drug

1.2.1 EMEA Bio-protein Drug Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Bio-protein Drug Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Monoclonal Antibodies

1.2.4 Therapeutic Proteins

1.2.5 Vaccines

1.3 EMEA Bio-protein Drug Market by Application/End Users

1.3.1 EMEA Bio-protein Drug Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Pharma and Biotech Companies

1.3.3 CROs

1.3.4 Academics

1.4 EMEA Bio-protein Drug Market by Region

1.4.1 EMEA Bio-protein Drug Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Bio-protein Drug (2012-2022)

1.5.1 EMEA Bio-protein Drug Sales and Growth Rate (2012-2022)

1.5.2 EMEA Bio-protein Drug Revenue and Growth Rate (2012-2022)

2 EMEA Bio-protein Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Bio-protein Drug Market Competition by Players/Manufacturers

2.1.1 EMEA Bio-protein Drug Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Bio-protein Drug Revenue and Share by Players (2012-2017)

2.1.3 EMEA Bio-protein Drug Sale Price by Players (2012-2017)

2.2 EMEA Bio-protein Drug (Volume and Value) by Type/Product Category

2.2.1 EMEA Bio-protein Drug Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Bio-protein Drug Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Bio-protein Drug Sale Price by Type (2012-2017)

2.3 EMEA Bio-protein Drug (Volume) by Application

2.4 EMEA Bio-protein Drug (Volume and Value) by Region

2.4.1 EMEA Bio-protein Drug Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Bio-protein Drug Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Bio-protein Drug Sales Price by Region (2012-2017)

3 Europe Bio-protein Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Bio-protein Drug Sales and Value (2012-2017)

3.1.1 Europe Bio-protein Drug Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Bio-protein Drug Revenue and Growth Rate (2012-2017)

3.2 Europe Bio-protein Drug Sales and Market Share by Type

3.3 Europe Bio-protein Drug Sales and Market Share by Application

3.4 Europe Bio-protein Drug Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Bio-protein Drug Sales Volume by Countries (2012-2017)

3.4.2 Europe Bio-protein Drug Revenue by Countries (2012-2017)

3.4.3 Germany Bio-protein Drug Sales and Growth Rate (2012-2017)

3.4.4 France Bio-protein Drug Sales and Growth Rate (2012-2017)

3.4.5 UK Bio-protein Drug Sales and Growth Rate (2012-2017)

3.4.6 Russia Bio-protein Drug Sales and Growth Rate (2012-2017)

3.4.7 Italy Bio-protein Drug Sales and Growth Rate (2012-2017)

3.4.8 Benelux Bio-protein Drug Sales and Growth Rate (2012-2017)

4 Middle East Bio-protein Drug (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Bio-protein Drug Sales and Value (2012-2017)

4.1.1 Middle East Bio-protein Drug Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Bio-protein Drug Revenue and Growth Rate (2012-2017)

4.2 Middle East Bio-protein Drug Sales and Market Share by Type

4.3 Middle East Bio-protein Drug Sales and Market Share by Application

4.4 Middle East Bio-protein Drug Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Bio-protein Drug Sales Volume by Countries (2012-2017)

4.4.2 Middle East Bio-protein Drug Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Bio-protein Drug Sales and Growth Rate (2012-2017)

4.4.4 Israel Bio-protein Drug Sales and Growth Rate (2012-2017)

4.4.5 UAE Bio-protein Drug Sales and Growth Rate (2012-2017)

4.4.6 Iran Bio-protein Drug Sales and Growth Rate (2012-2017)

5 Africa Bio-protein Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Bio-protein Drug Sales and Value (2012-2017)

5.1.1 Africa Bio-protein Drug Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Bio-protein Drug Revenue and Growth Rate (2012-2017)

5.2 Africa Bio-protein Drug Sales and Market Share by Type

5.3 Africa Bio-protein Drug Sales and Market Share by Application

5.4 Africa Bio-protein Drug Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Bio-protein Drug Sales Volume by Countries (2012-2017)

5.4.2 Africa Bio-protein Drug Revenue by Countries (2012-2017)

5.4.3 South Africa Bio-protein Drug Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Bio-protein Drug Sales and Growth Rate (2012-2017)

5.4.5 Egypt Bio-protein Drug Sales and Growth Rate (2012-2017)

5.4.6 Algeria Bio-protein Drug Sales and Growth Rate (2012-2017)

6 EMEA Bio-protein Drug Manufacturers/Players Profiles and Sales Data

6.1 Abbott Laboratories

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Bio-protein Drug Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Bayer AG

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Bio-protein Drug Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Bayer AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Eli Lilly and Company

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Bio-protein Drug Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Amgen Inc.

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Bio-protein Drug Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Biocon Ltd.

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Bio-protein Drug Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Dr. Reddy’s Laboratories

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Bio-protein Drug Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Roche

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Bio-protein Drug Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Roche Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Fresenius kabi

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Bio-protein Drug Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 GlaxoSmithKline

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Bio-protein Drug Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Johnson & Johnson

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Bio-protein Drug Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Merck

6.12 Novartis AG

6.13 Panacea Biotec

6.14 ProBioGen AG

6.15 Sanofi

6.16 Reliance Life Science Pvt. Ltd.

7 Bio-protein Drug Manufacturing Cost Analysis

7.1 Bio-protein Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Bio-protein Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Bio-protein Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Bio-protein Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Bio-protein Drug Market Forecast (2017-2022)

11.1 EMEA Bio-protein Drug Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Bio-protein Drug Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Bio-protein Drug Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Bio-protein Drug Price and Trend Forecast (2017-2022)

11.2 EMEA Bio-protein Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Bio-protein Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Bio-protein Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Bio-protein Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Bio-protein Drug Sales Forecast by Type (2017-2022)

11.7 EMEA Bio-protein Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Bio-protein Drug

Figure EMEA Bio-protein Drug Sales Volume (K Units) by Type (2012-2022)

Figure EMEA Bio-protein Drug Sales Volume Market Share by Type (Product Category) in 2016

Figure Monoclonal Antibodies Product Picture

Figure Therapeutic Proteins Product Picture

Figure Vaccines Product Picture

Figure EMEA Bio-protein Drug Sales Volume (K Units) by Application (2012-2022)

Figure EMEA Sales Market Share of Bio-protein Drug by Application in 2016

Figure Pharma and Biotech Companies Examples

Table Key Downstream Customer in Pharma and Biotech Companies

Figure CROs Examples

Table Key Downstream Customer in CROs

Figure Academics Examples

Table Key Downstream Customer in Academics

Figure EMEA Bio-protein Drug Market Size (Million USD) by Region (2012-2022)

Figure Europe Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Bio-protein Drug Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Bio-protein Drug Revenue (Million USD) Status and Forecast by Countries

Figure Africa Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Bio-protein Drug Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Bio-protein Drug Sales Volume and Growth Rate (2012-2022)

Figure EMEA Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Bio-protein Drug Market Major Players Product Sales Volume (K Units) (2012-2017)

Table EMEA Bio-protein Drug Sales Volume (K Units) of Major Players (2012-2017)

Table EMEA Bio-protein Drug Sales Share by Players (2012-2017)

Figure 2016 Bio-protein Drug Sales Share by Players

Figure 2017 Bio-protein Drug Sales Share by Players

Figure EMEA Bio-protein Drug Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Bio-protein Drug Revenue (Million USD) by Players (2012-2017)

Table EMEA Bio-protein Drug Revenue Share by Players (2012-2017)

Table 2016 EMEA Bio-protein Drug Revenue Share by Players

Table 2017 EMEA Bio-protein Drug Revenue Share by Players

Table EMEA Bio-protein Drug Sale Price (USD/Unit) by Players (2012-2017)

Table EMEA Bio-protein Drug Sales (K Units) and Market Share by Type (2012-2017)

Table EMEA Bio-protein Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of Bio-protein Drug by Type (2012-2017)

Figure EMEA Bio-protein Drug Sales Market Share by Type (2012-2017)

Table EMEA Bio-protein Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Bio-protein Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Bio-protein Drug by Type in 2016

Table EMEA Bio-protein Drug Sale Price (USD/Unit) by Type (2012-2017)

Table EMEA Bio-protein Drug Sales (K Units) and Market Share by Application (2012-2017)

Table EMEA Bio-protein Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of Bio-protein Drug by Application (2012-2017)

Figure EMEA Bio-protein Drug Sales Market Share by Application in 2016

Table EMEA Bio-protein Drug Sales (K Units) and Market Share by Region (2012-2017)

Table EMEA Bio-protein Drug Sales Share by Region (2012-2017)

Figure Sales Market Share of Bio-protein Drug by Region (2012-2017)

Figure EMEA Bio-protein Drug Sales Market Share in 2016

Table EMEA Bio-protein Drug Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Bio-protein Drug Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Bio-protein Drug by Region (2012-2017)

Figure EMEA Bio-protein Drug Revenue Market Share Regions in 2016

Table EMEA Bio-protein Drug Sales Price (USD/Unit) by Region (2012-2017)

Figure Europe Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Europe Bio-protein Drug Revenue and Growth Rate (2012-2017)

Table Europe Bio-protein Drug Sales (K Units) by Type (2012-2017)

Table Europe Bio-protein Drug Market Share by Type (2012-2017)

Figure Europe Bio-protein Drug Market Share by Type in 2016

Table Europe Bio-protein Drug Sales (K Units) by Application (2012-2017)

Table Europe Bio-protein Drug Market Share by Application (2012-2017)

Figure Europe Bio-protein Drug Market Share by Application in 2016

Table Europe Bio-protein Drug Sales (K Units) by Countries (2012-2017)

Table Europe Bio-protein Drug Sales Market Share by Countries (2012-2017)

Figure Europe Bio-protein Drug Sales Market Share by Countries (2012-2017)

Figure Europe Bio-protein Drug Sales Market Share by Countries in 2016

Table Europe Bio-protein Drug Revenue (Million USD) by Countries (2012-2017)

Table Europe Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Europe Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Europe Bio-protein Drug Revenue Market Share by Countries in 2016

Figure Germany Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure France Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure UK Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Russia Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Italy Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Benelux Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Middle East Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Middle East Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Bio-protein Drug Sales (K Units) by Type (2012-2017)

Table Middle East Bio-protein Drug Market Share by Type (2012-2017)

Figure Middle East Bio-protein Drug Market Share by Type (2012-2017)

Table Middle East Bio-protein Drug Sales (K Units) by Applications (2012-2017)

Table Middle East Bio-protein Drug Market Share by Applications (2012-2017)

Figure Middle East Bio-protein Drug Sales Market Share by Application in 2016

Table Middle East Bio-protein Drug Sales Volume (K Units) by Countries (2012-2017)

Table Middle East Bio-protein Drug Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Bio-protein Drug Sales Volume Market Share by Countries in 2016

Table Middle East Bio-protein Drug Revenue (Million USD) by Countries (2012-2017)

Table Middle East Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Middle East Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Middle East Bio-protein Drug Revenue Market Share by Countries in 2016

Figure Saudi Arabia Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Israel Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure UAE Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Iran Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Africa Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Africa Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Bio-protein Drug Sales (K Units) by Type (2012-2017)

Table Africa Bio-protein Drug Sales Market Share by Type (2012-2017)

Figure Africa Bio-protein Drug Sales Market Share by Type (2012-2017)

Figure Africa Bio-protein Drug Sales Market Share by Type in 2016

Table Africa Bio-protein Drug Sales (K Units) by Application (2012-2017)

Table Africa Bio-protein Drug Sales Market Share by Application (2012-2017)

Figure Africa Bio-protein Drug Sales Market Share by Application (2012-2017)

Table Africa Bio-protein Drug Sales Volume (K Units) by Countries (2012-2017)

Table Africa Bio-protein Drug Sales Market Share by Countries (2012-2017)

Figure Africa Bio-protein Drug Sales Market Share by Countries (2012-2017)

Figure Africa Bio-protein Drug Sales Market Share by Countries in 2016

Table Africa Bio-protein Drug Revenue (Million USD) by Countries (2012-2017)

Table Africa Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Africa Bio-protein Drug Revenue Market Share by Countries (2012-2017)

Figure Africa Bio-protein Drug Revenue Market Share by Countries in 2016

Figure South Africa Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Nigeria Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Egypt Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Algeria Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Table Abbott Laboratories Bio-protein Drug Basic Information List

Table Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abbott Laboratories Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Abbott Laboratories Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Abbott Laboratories Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Bayer AG Bio-protein Drug Basic Information List

Table Bayer AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bayer AG Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Bayer AG Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Bayer AG Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Eli Lilly and Company Bio-protein Drug Basic Information List

Table Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Eli Lilly and Company Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Eli Lilly and Company Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Eli Lilly and Company Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Amgen Inc. Bio-protein Drug Basic Information List

Table Amgen Inc. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Amgen Inc. Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Amgen Inc. Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Amgen Inc. Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Biocon Ltd. Bio-protein Drug Basic Information List

Table Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Biocon Ltd. Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Biocon Ltd. Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Biocon Ltd. Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Dr. Reddy’s Laboratories Bio-protein Drug Basic Information List

Table Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Dr. Reddy’s Laboratories Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Roche Bio-protein Drug Basic Information List

Table Roche Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Roche Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Roche Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Fresenius kabi Bio-protein Drug Basic Information List

Table Fresenius kabi Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Fresenius kabi Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Fresenius kabi Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Fresenius kabi Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table GlaxoSmithKline Bio-protein Drug Basic Information List

Table GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure GlaxoSmithKline Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure GlaxoSmithKline Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Johnson & Johnson Bio-protein Drug Basic Information List

Table Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Johnson & Johnson Bio-protein Drug Sales (K Units) and Growth Rate (2012-2017)

Figure Johnson & Johnson Bio-protein Drug Sales Market Share in EMEA (2012-2017)

Figure Johnson & Johnson Bio-protein Drug Revenue Market Share in EMEA (2012-2017)

Table Merck Bio-protein Drug Basic Information List

Table Novartis AG Bio-protein Drug Basic Information List

Table Panacea Biotec Bio-protein Drug Basic Information List

Table ProBioGen AG Bio-protein Drug Basic Information List

Table Sanofi Bio-protein Drug Basic Information List

Table Reliance Life Science Pvt. Ltd. Bio-protein Drug Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Bio-protein Drug

Figure Manufacturing Process Analysis of Bio-protein Drug

Figure Bio-protein Drug Industrial Chain Analysis

Table Raw Materials Sources of Bio-protein Drug Major Manufacturers in 2016

Table Major Buyers of Bio-protein Drug

Table Distributors/Traders List

Figure EMEA Bio-protein Drug Sales (K Units) and Growth Rate Forecast (2017-2022)

Figure EMEA Bio-protein Drug Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Bio-protein Drug Price (USD/Unit) and Trend Forecast (2017-2022)

Table EMEA Bio-protein Drug Sales (K Units) Forecast by Region (2017-2022)

Figure EMEA Bio-protein Drug Sales Market Share Forecast by Region (2017-2022)

Table EMEA Bio-protein Drug Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Bio-protein Drug Revenue Market Share Forecast by Region (2017-2022)

Table Europe Bio-protein Drug Sales (K Units) Forecast by Countries (2017-2022)

Figure Europe Bio-protein Drug Sales Market Share Forecast by Countries (2017-2022)

Table Europe Bio-protein Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Bio-protein Drug Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Bio-protein Drug Sales (K Units) Forecast by Countries (2017-2022)

Figure Middle East Bio-protein Drug Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Bio-protein Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Bio-protein Drug Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Bio-protein Drug Sales (K Units) Forecast by Countries (2017-2022)

Figure Africa Bio-protein Drug Sales Market Share Forecast by Countries (2017-2022)

Table Africa Bio-protein Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Bio-protein Drug Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Bio-protein Drug Sales (K Units) Forecast by Type (2017-2022)

Figure EMEA Bio-protein Drug Sales Market Share Forecast by Type (2017-2022)

Table EMEA Bio-protein Drug Sales (K Units) Forecast by Application (2017-2022)

Figure EMEA Bio-protein Drug Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources